Elf4 抗体 (C-Term)
Quick Overview for Elf4 抗体 (C-Term) (ABIN207363)
抗原
See all Elf4 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- C-Term
- 
                                            特异性
- Synthetic peptide corresponding to C-terminal residues of human ELF4 (ETS-related transcription factor Elf-4)
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide from human ELF4.
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, 0.01 % sodium azide, 50 % glycerol.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - Elf4 (E74 like ETS transcription factor 4 (Elf4))
- 
                                            别名
- ELF4 / MEF
- 
                                            背景
- 
                        Name/Gene ID: ELF4
 Synonyms: ELF4, E74-like factor 4, ELFR, MEF, Myeloid Elf-1-like factor
- 
                                            基因ID
- 2000
- 
                                            UniProt
- Q99607
- 
                                            途径
- Positive Regulation of Endopeptidase Activity
 抗原
- 
                    
 
                                     
                                     
                                    